Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02032264 · ClinicalTrials.gov registry record · NA

Next Generation Sequencing Screening for Embryonic Ploidy Status

A NA study of Infertility, sponsored by Reproductive Medicine Associates of New Jersey.

Completed
Registry status
NA
Development phase
309
Enrollment target
1
Study location

NCT02032264 is a NA study of Infertility that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 309 participants, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02032264, a NA study of Infertility, has completed, sponsored by Reproductive Medicine Associates of New Jersey.

COMPLETED
Registry status
NA
Development phase
309 participants
Enrollment target
1
Study location

Study Summary

To evaluate the benefits of using next generation sequencing to assess embryonic aneuploidy. All viable blastocysts will be biopsied and cryopreserved for future transfer. After the final embryo is cryopreserved, patients will be randomized to either the intervention group or the control group. Patients and doctors are blinded to the randomization until study completion. A Double Embryo Transfer (DET) will be performed with either screened or unscreened embryos depending on randomization. A Single Embryo Transfer (SET) may occur in cases where only one embryo is available for transfer.

Conditions Studied

Interventions

  • OTHER Comprehensive Chromosome Screening
  • OTHER Morphologically Best

Study Locations (1)

New Jersey

  • Reproductive Medicine Associates of New Jersey - Basking Ridge

Trial Details

FieldValue
Enrollment Target 309 participants
Start Date 2013-12
Est. Completion 2017-01
Phase NA

What the Registry Record Tells You About NCT02032264

The ClinicalTrials.gov registry entry for NCT02032264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 309 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,585-participant average among 74 other Infertility trials with a reported enrollment target (96% lower). The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 2 interventions - of which Comprehensive Chromosome Screening is the first listed.

NCT02032264 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02032264 about?

NCT02032264 is a clinical study titled "Next Generation Sequencing Screening for Embryonic Ploidy Status". To evaluate the benefits of using next generation sequencing to assess embryonic aneuploidy. All viable blastocysts will be biopsied and cryopreserved for future transfer. After the final embryo is cryopreserved, patients will be randomized to either the intervention group or the control group. Pati...

What is the current status of trial NCT02032264?

This trial is currently completed. It is a NA study. The enrollment target is 309 participants. The study started on 2013-12. Estimated completion is 2017-01.

What conditions does trial NCT02032264 study?

This clinical trial studies the following conditions: Infertility.

What interventions are being tested in trial NCT02032264?

The interventions under investigation include: Comprehensive Chromosome Screening (OTHER), Morphologically Best (OTHER).

Who is sponsoring clinical trial NCT02032264?

This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02032264 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.